Your browser doesn't support javascript.
loading
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
Chen, Gui-Ling; Yu, Xu-Ya; Luo, Li-Ping; Zhang, Fan; Dai, Xia-Hong; Li, Nan; Shen, Zhen-Wei; Wu, Kai-Qi; Lou, Dan-Feng; Peng, Cong-Gao; Jin, Ting-Han; Huang, Yu-Mei; Shao, Xi; Liu, Qi; Jiang, Qi; Guo, Tong; Cao, Fang; Zhu, Jing-Rui; Wu, Xiao-Hong; Pei, Rong-Juan; Deng, Fei; Jiang, Guo-Ping; Li, Yu-Hua; Gao, Hai-Nv; He, Jian-Xing; Peng, Yu-Cai; Li, Lan-Juan.
Affiliation
  • Chen GL; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, China; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Yu XY; AIM Vaccine Co. Ltd., Beijing, China.
  • Luo LP; Liverna Therapeutics Inc, Zhuhai, China.
  • Zhang F; AIM Vaccine Co. Ltd., Beijing, China.
  • Dai XH; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Li N; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Shen ZW; Zhejiang Shuren University, Shulan International Medical College, China.
  • Wu KQ; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Lou DF; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Peng CG; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Jin TH; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Huang YM; AIM Vaccine Co. Ltd., Beijing, China.
  • Shao X; AIM Vaccine Co. Ltd., Beijing, China.
  • Liu Q; Liverna Therapeutics Inc, Zhuhai, China.
  • Jiang Q; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Guo T; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China.
  • Cao F; AIM Vaccine Co. Ltd., Beijing, China.
  • Zhu JR; AIM Vaccine Co. Ltd., Beijing, China.
  • Wu XH; National Institutes for Food and Drug Control, Beijing, China.
  • Pei RJ; Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Deng F; Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Jiang GP; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China. Electronic address: guoping.jiang@shulan.com.
  • Li YH; National Institutes for Food and Drug Control, Beijing, China. Electronic address: liyuhua@nifdc.org.cn.
  • Gao HN; Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, China. Electronic address: hainv.gao@shulan.com.
  • He JX; Guangzhou Institute of Respiratory Health, Guangzhou, China. Electronic address: jianxing@gird.cn.
  • Zhong-Chen; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, China. Electronic address: chenzhong@zju.edu.com.
  • Peng YC; Liverna Therapeutics Inc, Zhuhai, China. Electronic address: pengyucai@live-rna.com.
  • Li LJ; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: ljli@zju.edu.cn.
Vaccine ; 41(48): 7297-7306, 2023 11 22.
Article in En | MEDLINE | ID: mdl-37925316
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adult / Humans Language: En Journal: Vaccine Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adult / Humans Language: En Journal: Vaccine Year: 2023 Type: Article Affiliation country: China